HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins.

Abstract
Hepatocellular carcinoma (HCC) development is characterized by the presence of epigenetic alterations, including promoter DNA hypermethylation and post-translational modifications of histone, which profoundly affect expression of a wide repertoire of genes critical for cancer development. Emerging data suggest that deregulation of polycomb group (PcG) proteins, which are key chromatin modifiers repressing gene transcription during developmental stage, plays a causative role in oncogenesis. PcG proteins assemble into polycomb repressive complex 1 (PRC1) and polycomb repressive complex 2 (PRC2) to impose the histone H3 lysine 27 trimethylation (H3K27me3) modification for repression. In this review, we will first recapitulate the mechanisms of two key epigenetic pathways: DNA methylation and histone modifications. Specifically, we will focus our discussion on the molecular roles of PcG proteins. Next, we will highlight recent findings on PcG proteins, their clinicopathological implication and their downstream molecular consequence in hepatocarcinogenesis. Last but not least, we will consider the therapeutic potential of targeting enhancer of zeste homolog 2 (EZH2) as a possible treatment for HCC. Improving our understanding on the roles of PcG proteins in hepatocarcinogenesis can benefit the development of epigenetic-based therapy.
AuthorsSandy Leung-Kuen Au, Irene Oi-Lin Ng, Chun-Ming Wong
JournalFrontiers of medicine (Front Med) Vol. 7 Issue 2 Pg. 231-41 (Jun 2013) ISSN: 2095-0225 [Electronic] China
PMID23620257 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Polycomb-Group Proteins
Topics
  • Carcinoma, Hepatocellular (genetics, metabolism)
  • Epigenomics (methods)
  • Humans
  • Liver Neoplasms (genetics, metabolism)
  • Polycomb-Group Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: